235 related articles for article (PubMed ID: 21112801)
21. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
22. Comparative expression pathway analysis of human and canine mammary tumors.
Uva P; Aurisicchio L; Watters J; Loboda A; Kulkarni A; Castle J; Palombo F; Viti V; Mesiti G; Zappulli V; Marconato L; Abramo F; Ciliberto G; Lahm A; La Monica N; de Rinaldis E
BMC Genomics; 2009 Mar; 10():135. PubMed ID: 19327144
[TBL] [Abstract][Full Text] [Related]
23. Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.
Król M; Pawłowski KM; Dolka I; Musielak O; Majchrzak K; Mucha J; Motyl T
Vet Res Commun; 2011 Oct; 35(7):409-23. PubMed ID: 21713436
[TBL] [Abstract][Full Text] [Related]
24. HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases.
Klopfleisch R; Klose P; da Costa A; Brunnberg L; Gruber AD
BMC Vet Res; 2010 Mar; 6():15. PubMed ID: 20226097
[TBL] [Abstract][Full Text] [Related]
25. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
[TBL] [Abstract][Full Text] [Related]
26. The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors.
Bujak JK; Szopa IM; Pingwara R; Kruczyk O; Krzemińska N; Mucha J; Majchrzak-Kuligowska K
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225066
[TBL] [Abstract][Full Text] [Related]
27. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
29. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study.
Martin de las Mulas J; Ordás J; Millán Y; Fernández-Soria V; Ramón y Cajal S
Breast Cancer Res Treat; 2003 Aug; 80(3):363-7. PubMed ID: 14503809
[TBL] [Abstract][Full Text] [Related]
30. Expression of inflammation-mediated cluster of genes as a new marker of canine mammary malignancy.
Pawłowski KM; Homa A; Bulkowska M; Majchrzak K; Motyl T; Król M
Vet Res Commun; 2013 Jun; 37(2):123-31. PubMed ID: 23435839
[TBL] [Abstract][Full Text] [Related]
31. Expression patterns of the erbB subfamily mRNA in canine benign and malignant mammary tumors.
Matsuyama S; Nakamura M; Yonezawa K; Shimada T; Ohashi F; Takamori Y; Kubo K
J Vet Med Sci; 2001 Sep; 63(9):949-54. PubMed ID: 11642281
[TBL] [Abstract][Full Text] [Related]
32. Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system.
van Garderen E; Schalken JA
Mol Cell Endocrinol; 2002 Nov; 197(1-2):153-65. PubMed ID: 12431808
[TBL] [Abstract][Full Text] [Related]
33. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
34. Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.
Delgado L; Gärtner F; Dias Pereira P
J Comp Pathol; 2015; 152(2-3):138-44. PubMed ID: 25670666
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of ATM Gene and Protein Expression in Canine Mammary Tumors.
Raposo-Ferreira TM; Bueno RC; Terra EM; Avante ML; Tinucci-Costa M; Carvalho M; Cassali GD; Linde SD; Rogatto SR; Laufer-Amorim R
Vet Pathol; 2016 Nov; 53(6):1154-1159. PubMed ID: 27106737
[TBL] [Abstract][Full Text] [Related]
36. Global gene expression profile in canine mammary carcinomas.
Varallo GR; Jardim-Perassi BV; Alexandre PA; Fukumasu H; Zuccari DAPC
Vet J; 2019 Dec; 254():105393. PubMed ID: 31836163
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
38. Expression and characterization of tissue inhibitor of metalloproteinase 4 from complex canine mammary carcinomas.
Kaur N; Sunil Kumar BV; Mahajan K; Singh S
J Immunoassay Immunochem; 2016; 37(5):515-26. PubMed ID: 26979595
[TBL] [Abstract][Full Text] [Related]
39. Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification.
Gama A; Alves A; Schmitt F
Virchows Arch; 2008 Aug; 453(2):123-32. PubMed ID: 18677512
[TBL] [Abstract][Full Text] [Related]
40. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]